|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.91 CNY | -0.82% |
|
-2.39% | -5.06% |
| 11-17 | Yifeng Pharmacy Chain Vice Presidents Reduce Stakes | MT |
| 10-29 | Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Capitalization | 27.78B 3.93B 3.38B 3.17B 2.95B 5.44B 353B 5.91B 36.76B 14.29B 167B 14.76B 14.44B 617B | P/E ratio 2025 * |
16.3x | P/E ratio 2026 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise value | 25.69B 3.64B 3.12B 2.93B 2.73B 5.03B 327B 5.47B 33.99B 13.21B 155B 13.65B 13.36B 571B | EV / Sales 2025 * |
1.04x | EV / Sales 2026 * | 0.92x |
| Free-Float |
45.78% | Yield 2025 * |
2.52% | Yield 2026 * | 2.88% |
| 1 day | -0.82% | ||
| 1 week | -2.39% | ||
| Current month | +1.28% | ||
| 1 month | -3.25% | ||
| 3 months | -11.51% | ||
| 6 months | -11.03% | ||
| Current year | -5.06% |
| 1 week | 22.84 |  | 23.53 |
| 1 month | 22.17 | | 25.52 |
| Current year | 22.17 | | 29.26 |
| 1 year | 22.17 | | 29.26 |
| 3 years | 17.56 | | 40.98 |
| 5 years | 17.56 | | 49.5 |
| 10 years | 7.9 | | 50.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Gao
CEO | Chief Executive Officer | 57 | 31/05/2008 |
Yong Hui Wang
DFI | Director of Finance/CFO | 50 | 24/06/2024 |
You Cheng Gao
PRN | Corporate Officer/Principal | 57 | 31/05/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
Yi Gao
CHM | Chairman | 57 | 31/05/2008 |
Feng Gao
BRD | Director/Board Member | 54 | 31/05/2008 |
You Cheng Gao
BRD | Director/Board Member | 57 | 31/05/2008 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.82% | -2.39% | -2.01% | -42.43% | 3.96B | |
| -1.50% | -6.61% | +104.84% | -33.59% | 24.77B | |
| -0.74% | -2.90% | +48.20% | -45.57% | 11.2B | |
| +1.04% | 0.00% | +25.41% | +37.74% | 7.27B | |
| -0.69% | -2.58% | -15.92% | +15.54% | 4.65B | |
| -0.45% | +0.46% | -18.20% | -39.60% | 3.46B | |
| 0.00% | +0.93% | -11.12% | +71.77% | 2.86B | |
| -0.17% | -3.22% | +12.59% | -52.33% | 2.81B | |
| +1.92% | -0.38% | +20.79% | - | 1.81B | |
| +0.63% | +3.07% | -6.30% | +15.60% | 1.76B | |
| Average | -0.08% | -1.55% | +15.83% | -8.10% | 6.46B | |
| Weighted average by Cap. | -0.65% | -2.87% | +49.68% | -19.37% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 24.7B 3.5B 3B 2.82B 2.63B 4.84B 314B 5.26B 32.69B 12.7B 149B 13.12B 12.84B 549B | 26.9B 3.81B 3.27B 3.07B 2.86B 5.27B 342B 5.72B 35.6B 13.84B 162B 14.29B 13.99B 598B |
| Net income | 1.7B 241M 207M 194M 181M 333M 21.66B 362M 2.25B 876M 10.27B 905M 886M 37.83B | 1.97B 279M 239M 225M 209M 385M 25.03B 419M 2.6B 1.01B 11.86B 1.05B 1.02B 43.71B |
| Net Debt | -2.09B -296M -254M -238M -222M -409M -26.57B -444M -2.76B -1.07B -12.59B -1.11B -1.09B -46.4B | -3.12B -442M -380M -357M -332M -612M -39.75B -665M -4.14B -1.61B -18.84B -1.66B -1.62B -69.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/12/25 | 22.91 ¥ | -0.82% | 6,096,633 |
| 08/12/25 | 23.10 ¥ | -0.94% | 6,641,370 |
| 05/12/25 | 23.32 ¥ | -0.09% | 6,463,584 |
| 04/12/25 | 23.34 ¥ | -0.89% | 5,033,420 |
| 03/12/25 | 23.55 ¥ | +0.34% | 10,926,730 |
End-of-day quote Shanghai S.E., December 08, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603939 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition